GB Sciences, Inc.
GBLX
$0.0003
$0.000150.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.04M | -1.13M | -1.37M | -1.36M | -3.76M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 600.00 | 600.00 |
| Total Amortization of Deferred Charges | 0.00 | 10.70K | 26.20K | 41.30K | 56.00K |
| Total Other Non-Cash Items | 0.00 | -85.00K | -100.80K | -58.60K | 2.32M |
| Change in Net Operating Assets | 536.50K | 616.60K | 555.90K | 402.80K | 444.60K |
| Cash from Operations | -506.50K | -587.60K | -892.40K | -975.70K | -943.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 85.00K | 320.00K | 320.00K | 320.00K |
| Cash from Investing | 0.00 | 85.00K | 320.00K | 320.00K | 320.00K |
| Total Debt Issued | 482.00K | 357.00K | 297.00K | 322.00K | 75.00K |
| Total Debt Repaid | -- | -- | -- | -- | -13.80K |
| Issuance of Common Stock | 10.00K | 43.30K | 263.50K | 253.50K | 333.50K |
| Repurchase of Common Stock | -17.80K | -17.80K | -17.80K | -17.80K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 17.80K | 17.80K | 0.00 | 0.00 | -28.20K |
| Cash from Financing | 492.00K | 400.30K | 542.70K | 557.70K | 366.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -14.50K | -102.30K | -29.70K | -98.00K | -256.60K |